Boehringer Ingelheim announces new R&D partnerships and progress
Boehringer Ingelheim announces new R&D partnerships and progress in multiple therapeutic areas, including oncology, cardiometabolic diseases, and mental health.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.